Developing skincare products for a global audience is a challenge many cosmetic and personal care professionals face. With differences in regulation, testing, labeling, and even base ingredients, finding a product that can be marketed and developed for various countries can prove incredibly difficult.
While some progress has been made in Europe by adopting ISO standards, some jurisdictions have yet to unify on an approach to what is accepted. The United States began efforts to speed up the FDA process of getting new sunscreens approved with the Sunscreen Innovation Act last December. Some ingredients such as amiloxate, enzacamene and octyl triazone, have been awaiting approval for 12 years. Other congressional action has been proposed in the form of a bill that would attempt to approve ingredients already approved in Europe within 90 days of it’s submission.
News Drill Down
- Cosmetics Design Europe gives an outline of the challenges of formulating a sunscreen as a global product and explains how some suncare products are listed as a drug, whereas others are listed as a cosmetic.
- In articles from the Regulatory Affairs Professionals Society, the challenges sunscreen has been through in the US are outlined as well as the recent FDA action on proposed ingredients. Another article outlines a new bill that proposes to speed up the approval process as well as harmonization efforts across countries.
- Health Canal interviews a skin cancer expert and gives a background on UV-A and UV-B radiation, as well as explains the new FDA rule that prohibits sunscreen from being labeled as “waterproof.”
Cosmetics Design Europe: The lowdown on global sunscreen regulation
RAPS:Under Pressure from Congress, FDA Holds Firm on Rejection of new Sunscreen Ingredients
Health Canal: Skin Cancer Expert Gives the 411 on Sunscreen
The views, opinions and technical analyses presented here are those of the author, and are not necessarily those of UL, ULProspector.com or Knowledge.ULProspector.com. While the editors of this site make every effort to verify the accuracy of its content, we assume no responsibility for errors made by the author, editorial staff or any other contributor. All content is subject to copyright and may not be reproduced without prior authorization from Prospector.